These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1846 related items for PubMed ID: 16968819

  • 21. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK, Verma I, Khuller GK.
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [Abstract] [Full Text] [Related]

  • 22. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain.
    Ballesteros C, Garrido JM, Vicente J, Romero B, Galindo RC, Minguijón E, Villar M, Martín-Hernando MP, Sevilla I, Juste R, Aranaz A, de la Fuente J, Gortázar C.
    Vaccine; 2009 Nov 12; 27(48):6662-8. PubMed ID: 19747578
    [Abstract] [Full Text] [Related]

  • 23. Immunization of mice with Mycobacterium leprae/Mycobacterium bovis BCG admixtures: modulation of the acquired response to BCG.
    Orme IM.
    Int J Lepr Other Mycobact Dis; 1987 Jun 12; 55(2):293-8. PubMed ID: 3298475
    [Abstract] [Full Text] [Related]

  • 24. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
    Hope JC, Thom ML, Villarreal-Ramos B, Vordermeier HM, Hewinson RG, Howard CJ.
    Clin Exp Immunol; 2005 Jan 12; 139(1):48-56. PubMed ID: 15606613
    [Abstract] [Full Text] [Related]

  • 25. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T, Lasco TM, Uchida K, Goto Y, Jeevan A, McFarland C, Ly L, Yamamoto S, McMurray DN.
    Tuberculosis (Edinb); 2007 Mar 12; 87(2):155-65. PubMed ID: 17289434
    [Abstract] [Full Text] [Related]

  • 26. Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis.
    Corner LA, Costello E, O'Meara D, Lesellier S, Aldwell FE, Singh M, Hewinson RG, Chambers MA, Gormley E.
    Vaccine; 2010 Aug 31; 28(38):6265-72. PubMed ID: 20637774
    [Abstract] [Full Text] [Related]

  • 27. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE, Cross ML, Fitzpatrick CE, Lambeth MR, de Lisle GW, Buddle BM.
    Vaccine; 2006 Mar 15; 24(12):2071-8. PubMed ID: 16332403
    [Abstract] [Full Text] [Related]

  • 28. Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis.
    Price DN, Kusewitt DF, Lino CA, McBride AA, Muttil P.
    PLoS Pathog; 2016 May 15; 12(5):e1005614. PubMed ID: 27153120
    [Abstract] [Full Text] [Related]

  • 29. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J, Wilkens M, Dohmann K, Gerlach GF.
    Vet Microbiol; 2008 Aug 25; 130(3-4):330-7. PubMed ID: 18343053
    [Abstract] [Full Text] [Related]

  • 30. Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.
    Hogarth PJ, Logan KE, Vordermeier HM, Singh M, Hewinson RG, Chambers MA.
    Vaccine; 2005 Apr 08; 23(20):2557-64. PubMed ID: 15780437
    [Abstract] [Full Text] [Related]

  • 31. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.
    Vaccine; 2009 Jan 01; 27(1):28-37. PubMed ID: 18977269
    [Abstract] [Full Text] [Related]

  • 32. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi.
    Black GF, Dockrell HM, Crampin AC, Floyd S, Weir RE, Bliss L, Sichali L, Mwaungulu L, Kanyongoloka H, Ngwira B, Warndorff DK, Fine PE.
    J Infect Dis; 2001 Aug 01; 184(3):322-9. PubMed ID: 11443558
    [Abstract] [Full Text] [Related]

  • 33. Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis.
    Griffin JF, Mackintosh CG, Rodgers CR.
    Vaccine; 2006 Feb 06; 24(6):835-45. PubMed ID: 16098638
    [Abstract] [Full Text] [Related]

  • 34. A key role for lung-resident memory lymphocytes in protective immune responses after BCG vaccination.
    Connor LM, Harvie MC, Rich FJ, Quinn KM, Brinkmann V, Le Gros G, Kirman JR.
    Eur J Immunol; 2010 Sep 06; 40(9):2482-92. PubMed ID: 20602436
    [Abstract] [Full Text] [Related]

  • 35. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine.
    Pinto R, Saunders BM, Camacho LR, Britton WJ, Gicquel B, Triccas JA.
    J Infect Dis; 2004 Jan 01; 189(1):105-12. PubMed ID: 14702160
    [Abstract] [Full Text] [Related]

  • 36. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. II. Suppression of protective immunity].
    Nakamura RM.
    Kekkaku; 1993 May 01; 68(5):361-5. PubMed ID: 8331880
    [Abstract] [Full Text] [Related]

  • 37. Increased protection against bovine tuberculosis in the brushtail possum (Trichosurus vulpecula) when BCG is administered with killed Mycobacterium vaccae.
    Skinner MA, Keen DL, Parlane NA, Yates GF, Buddle BM.
    Tuberculosis (Edinb); 2002 May 01; 82(1):15-22. PubMed ID: 11914058
    [Abstract] [Full Text] [Related]

  • 38. Neonatal revaccination with Bacillus Calmette-Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice.
    Li W, Huang H, Hua W, Ben S, Liu H, Xu B, Xian Q, Tang Z, Shen H.
    Vaccine; 2012 May 02; 30(21):3223-30. PubMed ID: 22342709
    [Abstract] [Full Text] [Related]

  • 39. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
    Goter-Robinson C, Derrick SC, Yang AL, Jeon BY, Morris SL.
    Vaccine; 2006 Apr 24; 24(17):3522-9. PubMed ID: 16519971
    [Abstract] [Full Text] [Related]

  • 40. Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice.
    Appelberg R, Castro AG, Pedrosa J, Minóprio P.
    Immunology; 1994 Jul 24; 82(3):361-4. PubMed ID: 7959868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 93.